Austin, TX—Regenerative medicine is growing fast, and was a hot topic at this year’s SXSW event in Austin, TX. According to the Mayo Clinic, “Regenerative medicine is a game-changing area of medicine with the potential to fully heal damaged tissues and organs, offering solutions and hope for people who have conditions that today are beyond repair.” It’s not all about 3D printing organs, which is what many people think of first these days when they hear about regenerative medicine; innovations like that begin on a much smaller scale–with cells. One of the companies innovating in this area, Orig3n, has developed LifeCapsule, the world’s largest blood cell repository dedicated to supporting regenerative medicine. You might have heard about this if you were recently at SXSW, where Orig3n was recognized as an innovator.

As a LifeCapsule member, you contribute a blood sample so Orig3n can store your iPS cells, which can become any cell type in the body. They’re used to find new treatments for rare diseases, and are also stored for your own personal use if you need them in the future. Sign us up.

Why this matters:

LifeCapsule empowers individuals by showing them how they personally can help to advance regenerative medicine, and healthcare as a whole. It also gives them control over their own health and wellness by ensuring that they can access their cells if needed. Plus, membership is $99 a year, which is much more affordable than a yearly cable subscription. Affordability means accessibility, so there’s greater diversity in submitted samples and therefore greater potential to cure a vast range of diseases.

Learn more about LifeCapsule and become a member here.

About the Author:

As Managing Director of Innovation and Insights for Syneos Health Communications, Leigh is responsible for building and scaling a global team of healthcare experts who together help life science leaders better understand the complex lives, influences and expectations of their customers. Specifically, they uncover actionable insights that fuel empathy and creativity; lead co-creation events that let marketers learn from peers, trends, and new possibilities; and help clients identify the most valuable and useful new customer experiences to create.

Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for nearly 20 years.She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she held several leadership roles at our largest agency, GSW.  There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business.

Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes.

A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. This year, she led over 250 experts to experts to focus on the most important changes in the commercial, consumer, marketing, digital and healthcare landscapes. (See reports at

Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice and Top 10 Innovation Catalysts of 2017 by MM&M, Leigh also was recognized  as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.